Cost-effectiveness of fenofibrate versus standard care for reducing the progression of diabetic retinopathy: an economic evaluation based on data from the LENS trial
PREISS D., SAMMONS E., Zayed M., EMBERSON J., WADE R., WALLENDSZUS K., STEVENS W., Cretney R., ARMITAGE J.